7th Nov 2006 10:31
GlaxoSmithKline PLC07 November 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 30 October 2006 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 6 November 2006 that 3,118 Ordinary shares in the Company had been sold on 30 October 2006 on behalf of participants in the SmithKline Beecham Bonus Investment Plan at a price of £13.99 per share. The Trust also notified the Company on 6 November 2006 that 3,441 Ordinary shares had been transferred from the Trust to a participant in the SmithKline Beecham Bonus Investment Plan. 30 October 2006 The Trust notified the Company on 6 November 2006 that 1,860 Ordinary shares in the Company had been sold on 30 October 2006 on behalf of participants in the SmithKline Beecham Annual Investment Plan at a price of £13.99 per share. The Trust also notified the Company on 6 November 2006 that 2,053 Ordinary shares had been transferred from the Trust to a participant in the SmithKline Beecham Annual Investment Plan. 31 October 2006 The Trust notified the Company on 6 November 2006 that 1,660 Ordinary shares in the Company had been sold on 31 October 2006 on behalf of participants in the SmithKline Beecham Annual Investment Plan at a price of £14.03 per share. The Trust also notified the Company on 6 November 2006 that 5,544 Ordinary shares had been transferred from the Trust to a participant in the SmithKline Beecham Annual Investment Plan. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, Mr J Heslop is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 7 November 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline